The U.S. Food and Drug Administration and the National Telecommunications and Information Administration (NTIA) are launching a 120-day pilot to help reduce the availability of unapproved opioids illegally offered for sale online
Market | 09/06/2020 | By Darshana | 484
Merck and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have entered into a collaboration agreement to develop EIDD-2801, an orally available antiviral candidate currently in early clinical development for the treatment of patients with COVID-19
Market | 28/05/2020 | By Darshana | 432
Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use
Roche today announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche's nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX).
Market | 22/05/2020 | By Darshana | 539
Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6 crore
Dr Lal PathLabs Limited, a leading diagnostic and related healthcare service provider posted 31% dip in net profit at Rs. 32.6 crore for the fourth quarter ended March 31, 2020 as compared to Rs. 47.4 crore in Q4 last year
Market | 19/05/2020 | By Darshana | 403
Roche today announced that new data from clinical trials of 19 approved and investigational medicines across 21 cancer types, will be presented at the ASCO20 Virtual Scientific Program organised by the American Society of Clinical Oncology (ASCO), which will be held 29-31 May, 2020
Market | 08/05/2020 | By Darshana | 393
IIT Guwahati collaborates with Hester Biosciences Limited to develop vaccine against COVID-19
Indian Institute of Technology Guwahati is collaborating with Hester Biosciences Limited, a pharmaceutical company based in Ahmedabad, Gujarat, to work on the vaccine development against COVID-19. The agreement between the two parties was signed on 15th April 2020
Market | 29/04/2020 | By Darshana | 295
Syngene International opens COVID-19 RT-PCR testing centre to support Bengaluru hospitals
Syngene International Ltd., a global research and development services company, today announced the opening of a COVID-19 testing laboratory at its Bengaluru site. In less than six weeks, the company used its expertise in clinical trial management
Market | 28/04/2020 | By Darshana | 726
Today, the U.S. Food and Drug Administration granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with triple-negative breast cancer that has spread to other parts of the body. Patients must have received at least two prior therapies before taking Trodelvy
Market | 25/04/2020 | By Darshana | 585
Uber partners Medlife to ensure medicine deliveries across 5 cities
As our battle as a people against COVID-19 intensifies, and stricter norms get put in place to flatten the curve, it is crucial that we all stay at home, and that we stay healthy while at home
Market | 19/04/2020 | By Darshana | 270
Lupin's Mandideep Unit II Facility Receives EIR from U.S. FDA
Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) after closure of the U.S. FDA inspection of its Mandideep Unit II facility, classifying the inspection as Voluntary Action Indicated. The inspection at the facility was carried out by the U.S. FDA between November 26, 2018 and December 4, 2018
Market | 15/04/2020 | By Darshana | 257
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy